100 related articles for article (PubMed ID: 1957751)
1. Differentiation of reperfused-viable (stunned) from reperfused-infarcted myocardium at 1 to 3 days postreperfusion by in vivo phosphorus-31 nuclear magnetic resonance spectroscopy.
Rehr RB; Fuhs BE; Lee F; Tatum JL; Hirsch JI; Quint R
Am Heart J; 1991 Dec; 122(6):1571-82. PubMed ID: 1957751
[TBL] [Abstract][Full Text] [Related]
2. Reperfused-viable and reperfused-infarcted myocardium: differentiation with in vivo P-31 MR spectroscopy.
Rehr RB; Tatum JL; Hirsch JI; Quint R; Clarke G
Radiology; 1989 Jul; 172(1):53-8. PubMed ID: 2740521
[TBL] [Abstract][Full Text] [Related]
3. Effective separation of normal, acutely ischemic, and reperfused myocardium with P-31 MR spectroscopy.
Rehr RB; Tatum JL; Hirsch JI; Wetstein L; Clarke G
Radiology; 1988 Jul; 168(1):81-9. PubMed ID: 3380986
[TBL] [Abstract][Full Text] [Related]
4. Early differentiation of infarcted and noninfarcted reperfused myocardium in dogs by quantitative analysis of regional myocardial echo amplitudes.
Haendchen RV; Ong K; Fishbein MC; Zwehl W; Meerbaum S; Corday E
Circ Res; 1985 Nov; 57(5):718-28. PubMed ID: 4053305
[TBL] [Abstract][Full Text] [Related]
5. [Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].
Baer FM; Theissen P; Schneider CA; Voth E; Schicha H; Sechtem U
Herz; 1994 Feb; 19(1):51-64. PubMed ID: 8150414
[TBL] [Abstract][Full Text] [Related]
6. MRI of reperfused myocardial infarct in dogs.
Tscholakoff D; Higgins CB; Sechtem U; Caputo G; Derugin N
AJR Am J Roentgenol; 1986 May; 146(5):925-30. PubMed ID: 3485909
[TBL] [Abstract][Full Text] [Related]
7. Differentiation of viable and nonviable myocardium by the use of three-dimensional tagged MRI in 2-day-old reperfused canine infarcts.
Croisille P; Moore CC; Judd RM; Lima JA; Arai M; McVeigh ER; Becker LC; Zerhouni EA
Circulation; 1999 Jan; 99(2):284-91. PubMed ID: 9892596
[TBL] [Abstract][Full Text] [Related]
8. MR imaging of contrast-enhanced porcine myocardial infarction. Assessment of reperfusion and tissue viability.
Nilsson S
Acta Radiol Suppl; 1995; 397():1-44. PubMed ID: 7484207
[TBL] [Abstract][Full Text] [Related]
9. Stunned, infarcted, and normal myocardium in dogs: simultaneous differentiation by using gadolinium-enhanced cine MR imaging with magnetization transfer contrast.
Weiss CR; Aletras AH; London JF; Taylor JL; Epstein FH; Wassmuth R; Balaban RS; Arai AE
Radiology; 2003 Mar; 226(3):723-30. PubMed ID: 12616019
[TBL] [Abstract][Full Text] [Related]
10. Myocardial technetium 99m sestamibi kinetics after reperfusion in a canine model.
Glover DK; Okada RD
Am Heart J; 1993 Mar; 125(3):657-66. PubMed ID: 8438693
[TBL] [Abstract][Full Text] [Related]
11. Early assessment of tissue viability with radioiodinated heptadecanoic acid in reperfused canine myocardium: comparison with thallium-201.
Chappuis F; Meier B; Belenger J; Bläuenstein P; Lerch R
Am Heart J; 1990 Apr; 119(4):833-41. PubMed ID: 1690945
[TBL] [Abstract][Full Text] [Related]
12. Myocardial hypertrophy in the ischemic zone induced by exercise in rats after coronary reperfusion.
Oh BH; Ono S; Rockman HA; Ross J
Circulation; 1993 Feb; 87(2):598-607. PubMed ID: 8425304
[TBL] [Abstract][Full Text] [Related]
13. Assessment of postreperfusion myocardial hemorrhage using proton NMR imaging at 1.5 T.
Lotan CS; Bouchard A; Cranney GB; Bishop SP; Pohost GM
Circulation; 1992 Sep; 86(3):1018-25. PubMed ID: 1516171
[TBL] [Abstract][Full Text] [Related]
14. Effect of hyperosmotic mannitol on magnetic resonance relaxation parameters in reperfused canine myocardial infarction.
Miller DD; Johnston DL; Dragotakes D; Newell JB; Aretz T; Kantor HL; Brady TJ; Okada RD
Magn Reson Imaging; 1989; 7(1):79-88. PubMed ID: 2493119
[TBL] [Abstract][Full Text] [Related]
15. The fate of inorganic phosphate and pH in regional myocardial ischemia and infarction: a noninvasive 31P NMR study.
Bottomley PA; Smith LS; Brazzamano S; Hedlund LW; Redington RW; Herfkens RJ
Magn Reson Med; 1987 Aug; 5(2):129-42. PubMed ID: 3657502
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of myocardial viability following ischemic and reperfusion injury using phosphorus 31 nuclear magnetic resonance spectroscopy in vivo.
Wroblewski LC; Aisen AM; Swanson SD; Buda AJ
Am Heart J; 1990 Jul; 120(1):31-9. PubMed ID: 2360515
[TBL] [Abstract][Full Text] [Related]
17. Characterization of high-energy phosphate compounds during reperfusion of the irreversibly injured myocardium using 31P MRS.
Wendland MF; White RD; Derugin N; Finkbeiner WE; McNamara MT; Moseley ME; Lipton MJ; Higgins CB
Magn Reson Med; 1988 Jun; 7(2):172-83. PubMed ID: 3398764
[TBL] [Abstract][Full Text] [Related]
18. Coronary hemodynamics during reperfusion following acute coronary ligation in dogs.
Parker PE; Bashour FA; Downey HF; Kechejian SJ; Williams AG
Am Heart J; 1975 Nov; 90(5):593-9. PubMed ID: 1190037
[TBL] [Abstract][Full Text] [Related]
19. Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium.
Wesbey GE; Higgins CB; McNamara MT; Engelstad BL; Lipton MJ; Sievers R; Ehman RL; Lovin J; Brasch RC
Radiology; 1984 Oct; 153(1):165-9. PubMed ID: 6473778
[TBL] [Abstract][Full Text] [Related]
20. Microvascular injury in reperfused infarcted myocardium: noninvasive assessment with contrast-enhanced echoplanar magnetic resonance imaging.
Bremerich J; Wendland MF; Arheden H; Wyttenbach R; Gao DW; Huberty JP; Dae MW; Higgins CB; Saeed M
J Am Coll Cardiol; 1998 Sep; 32(3):787-93. PubMed ID: 9741528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]